RANDOMIZED TRIAL OF OPG 14117 IN HUNTINGTONS DISEASE

Project: Research project

Project Details

Description

This is an investigator initiated, multicenter, 20 week, double-blind,randomized placebo controlled trial of the tolerability and efficacy of 3 dosages of OPC-14117 (60,120,240) or placebo in ambulatory patients with Huntington's disease.
StatusFinished
Effective start/end date10/1/959/30/96

Funding

  • National Center for Research Resources

ASJC Scopus Subject Areas

  • Clinical Neurology
  • Neurology

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.